Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xian-wei Cui
A Novel Peptide RIFV Suppresses Human Adipocyte Differentiation Through the Inhibition of C/EBP-β Expression
Nutrition and Metabolism
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
Related publications
Transcriptional Regulation of Adipocyte Differentiation: A Central Role for CCAAT/Enhancer-binding Protein (C/Ebp) Β
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Cascade Regulation of Terminal Adipocyte Differentiation by Three Members of the C/Ebp Family of Leucine Zipper Proteins.
Genes and Development
Genetics
Developmental Biology
Chibby Suppresses Growth of Human SW480 Colon Adenocarcinoma Cells Through Inhibition of Β-Catenin Signaling
Journal of Molecular Signaling
Biochemistry
Cell Biology
Molecular Biology
Identification of 1,2,3-Triazole Derivatives That Protect Pancreatic Β Cells Against Endoplasmic Reticulum Stress-Mediated Dysfunction and Death Through the Inhibition of C/EBP-homologous Protein Expression
Bioorganic and Medicinal Chemistry
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
Depletion of White Adipocyte Progenitors Induces Beige Adipocyte Differentiation and Suppresses Obesity Development
Cell Death and Differentiation
Cell Biology
Molecular Biology
Cloning of the Novel Human Myeloid-Cell-Specific C/EBP-epsilon Transcription Factor.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Regulation of Gene Expression During Adipocyte Differentiation: A Review
Journal of Animal Science
Animal Science
Zoology
Genetics
Medicine
Food Science
Progesterone Induces Expression of the Prolactin Receptor Gene Through Cooperative Action of Sp1 and C/Ebp
Molecular and Cellular Endocrinology
Biochemistry
Endocrinology
Molecular Biology
miR-191 Promotes Tumorigenesis of Human Colorectal Cancer Through Targeting C/EBPβ
Oncotarget
Oncology